Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video Observations
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study will be used to evaluate how patients put eye drops in their eyes and any problems that may arise from this activity. The information gathered will help identify common problems patients are having with putting in their eye medications. Then doctors can be better informed about the issues and provide better advice to their patients to overcome these problems.
| Condition |
|---|
|
Glaucoma Dry Eye Syndrome Conjunctivitis |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Evaluation of Eye Drop Administration in Glaucoma Patients |
| Enrollment: | 200 |
| Study Start Date: | February 2007 |
| Study Completion Date: | July 2007 |
Approximately 100 patients will take part in a one time procedure and survey as part of this project. After appropriate consent patients are asked to complete a short 2 page survey about themselves and their eye drops. Then a video recording will be made of the patient instilling eye drops in their habitual manner. The eye drops used will be sterile saline placed in either Travatan-like or Systane bottles to simulate the corresponding prescribed medication. The videos will be graded for instillation technique and combined with scoring of survey answers.
Patients will be asked to instill the drops to their left eye with their dominant hand as we expect this to be most difficult. Patients with severe (>20/200) vision loss will instill drops into their better seeing eye.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
173 subjects enrolled and 222 video recordings were made. Ages ranged from 21-94 years old (mean:67 yrs) and subjects were 55% female and 70% caucasian.
Inclusion Criteria:
- Currently using topical glaucoma medications
Contacts and Locations| United States, Maryland | |
| ALan L Robin MD PA | |
| Baltimore, Maryland, United States, 21209 | |
| Principal Investigator: | Jennifer L Stone, OD | Alan L Robin MD PA |
| Study Director: | Alan L Robin, MD | Alan L Robin MD PA |
More Information
Additional Information:
No publications provided by Robin, Alan L., M.D.
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Jennifer L. Stone, OD, Glaucoma Specialists |
| ClinicalTrials.gov Identifier: | NCT00522600 History of Changes |
| Other Study ID Numbers: | SI0717 |
| Study First Received: | August 29, 2007 |
| Last Updated: | July 21, 2009 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Robin, Alan L., M.D.:
|
eyedrops compliance glaucoma medications adherence |
Additional relevant MeSH terms:
|
Conjunctivitis Dry Eye Syndromes Keratoconjunctivitis Sicca Glaucoma Conjunctival Diseases Eye Diseases Lacrimal Apparatus Diseases Keratoconjunctivitis Keratitis Corneal Diseases Ocular Hypertension |
Tetrahydrozoline Nasal Decongestants Vasoconstrictor Agents Cardiovascular Agents Therapeutic Uses Pharmacologic Actions Respiratory System Agents Sympathomimetics Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs |
ClinicalTrials.gov processed this record on May 16, 2013